Maple Rock Capital Partners Inc. Bausch & Lomb Corp Transaction History
Maple Rock Capital Partners Inc.
- $2.6 Billion
- Q1 2025
A detailed history of Maple Rock Capital Partners Inc. transactions in Bausch & Lomb Corp stock. As of the latest transaction made, Maple Rock Capital Partners Inc. holds 1,971,053 shares of BLCO stock, worth $23.1 Million. This represents 1.1% of its overall portfolio holdings.
Number of Shares
1,971,053
Previous 3,171,053
37.84%
Holding current value
$23.1 Million
Previous $57.4 Million
50.23%
% of portfolio
1.1%
Previous 1.8%
Shares
8 transactions
Others Institutions Holding BLCO
# of Institutions
127Shares Held
37.8MCall Options Held
744KPut Options Held
699K-
Deutsche Bank Ag\ Frankfurt Am Main, 2M3.5MShares$41.1 Million0.02% of portfolio
-
Icahn Carl C Sunny Isles Beach, FL3.5MShares$41.1 Million0.68% of portfolio
-
Alberta Investment Management Corp Edmonton, A03.27MShares$38.3 Million0.36% of portfolio
-
Goldentree Asset Management LP New York, NY2.25MShares$26.4 Million2.88% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.88MShares$22 Million0.03% of portfolio
About Bausch & Lomb Corp
- Ticker BLCO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 350,000,000
- Market Cap $4.11B
- Description
- Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...